Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$26.68 -0.71 (-2.59%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Total Non-Current Liabilities (2014 - 2026)

Updated

Amphastar Pharmaceuticals (AMPH) recorded Total Non-Current Liabilities of $946.17 million in Q2 2026, up 14.0% from $830.06 million a year earlier and up 11.9% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, Amphastar Pharmaceuticals reported Total Non-Current Liabilities of $810.52 million, down 1.7% from FY2024.

  • Annual Total Non-Current Liabilities has a five-year compound annual growth rate of 36.8% (FY2020 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $824.23 million in FY2024 (-3.1%), $850.77 million in FY2023 (+328.0%), $198.76 million in FY2022 (-5.5%) and $210.35 million in FY2021 (+24.2%).
  • The Q2 2026 figure is the highest quarterly Total Non-Current Liabilities in data going back to Q4 2014.
  • On a year-over-year basis, Total Non-Current Liabilities rose in three of the last eight quarters, with growth averaging 0.9%.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 350.4% in Q3 2023, against a decline of 15.3% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $845.41 million (Q1 2026), $810.52 million (Q4 2025) and $860.21 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Amphastar Pharmaceuticals 1.16 Bn 23.86 Mn 93.47 Mn 946.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 946.17 Mn
Mar 31, 2026 845.41 Mn
Dec 31, 2025 810.52 Mn
Sep 30, 2025 860.21 Mn
Jun 30, 2025 830.06 Mn
Mar 31, 2025 850.57 Mn
Dec 31, 2024 824.23 Mn
Sep 30, 2024 790.46 Mn
Jun 30, 2024 759.37 Mn
Mar 31, 2024 883.98 Mn
Dec 31, 2023 850.77 Mn
Sep 30, 2023 933.79 Mn
Jun 30, 2023 771.40 Mn
Mar 31, 2023 209.90 Mn
Dec 31, 2022 198.76 Mn
Sep 30, 2022 207.34 Mn
Jun 30, 2022 209.08 Mn
Mar 31, 2022 221.22 Mn
Dec 31, 2021 210.35 Mn
Sep 30, 2021 206.62 Mn
API Access

Amphastar Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=AMPH&period=max&api_key=YOUR_API_KEY